The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A platform to identify patients for cancer vaccine trials: The NHS England Cancer Vaccine Launch Pad (CVLP).
 
Victoria Goss
No Relationships to Disclose
 
Nicole Keyworth
No Relationships to Disclose
 
Dan Muller
No Relationships to Disclose
 
Sam Wilding
No Relationships to Disclose
 
Simon Crabb
Honoraria - Amgen; Amphista Therapeutics; Astellas Oncology; AstraZeneca/UK; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Merck; MSD; Novartis; Pfizer; Roche
Research Funding - Astex Pharmaceuticals; AstraZeneca/UK; Clovis Oncology; Pfizer; Roche
 
Emily Shaw
No Relationships to Disclose
 
Nicola Chapman-Hart
No Relationships to Disclose
 
Max Shen
No Relationships to Disclose
 
Patrick Ezeani
No Relationships to Disclose
 
Gillian Rosenberg
No Relationships to Disclose
 
Gareth Griffiths
Honoraria - Abbvie; AstraZeneca
Research Funding - Astex Pharmaceuticals (Inst); AstraZeneca (Inst); BionTEch (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Heartflow (Inst); Heartflow (Inst); Jannsenn-Cilag (Inst); Novartis (Inst); Roche (Inst)
 
Peter Johnson
Honoraria - Pentixapharm
Patents, Royalties, Other Intellectual Property - Combined use of Fc gamma RIIb (CD32b) and CD20 - specific antibodies. WO Patent, PCT/GB2011/051572; EU11760819.0